You also may be interested in...
Fact Sheet
10/9/2002
The purpose of DTC Test 69-14 was to determine the hazards associated with inadvertent release of the MC-1 bomb during takeoff and landing, as well as the hazards resulting from bomb damage caused by hostile fire.
Fact Sheet
10/9/2002
Devil Hole, Phase II was conducted in temperate aspen and spruce forested terrain to provide weapons effects information for artillery delivered VX nerve agent-filled shells. The munitions used were M121A1 (155m) and M426 (8-inch) artillery shells filled with VX nerve agent.
Fact Sheet
10/9/2002
Deseret Test Center Test 68-13 (Rapid Tan I, II, III) was a joint U.S., U.K., and Canadian program designed to investigate the extent and duration of hazard following a Tabun, Soman or V nerve agent attack.
Fact Sheet
10/9/2002
The primary purpose of Night Train was to study the penetration of an arctic inversion by a biological aerosol cloud.
Fact Sheet
10/9/2002
The primary test objective of Deseret Test Center (DTC) Test 68-53 was to establish safety distances downwind of CS2 drop zones. A secondary objective required the determination of agent deposition patterns, percent of agent recovery, and airborne agent particle size in defining direct assault effects such as those related to rescue missions.
Fact Sheet
10/9/2002
The purpose of Tall Timber was to test the effectiveness of the M138 bomblet filled with agent BZ in a tropical forested environment.
Fact Sheet
10/9/2002
The purpose of West Side, Phase I was to evaluate the A/B 45Y-4 dry agent disseminator in a frigid environment.
Fact Sheet
10/9/2002
The Elk Hunt, Phase I tests were designed to determine the amount of either standard or modified VX nerve agent picked up on the clothing of personnel traversing various types of contaminated terrain.
Fact Sheet
10/9/2002
The objective of Deseret Test Center (DTC) Test 69-75 was to investigate the effectiveness of the F-4/A/B 45Y-2/TX weapon system to reduce wheat crop yields in selected geographic areas.
Fact Sheet
10/9/2002
In 1967 and 1968, Deseret Test Center Test conducted DTC Test 68-13 (Rapid Tan I, II, III) jointly with the United Kingdom and Canada. Rapid Tan was designed to investigate the extent and duration of hazard following a Tabun, Soman or V nerve agent attack. DTC Test 69-12 was planned as a more sophisticated test than Rapid Tan.
Fact Sheet
10/9/2002
The purpose of the Half Note test was to determine biological decay rates of vegetative nonpathogens in a marine environment and to compare the field decay rates with chamber decay rates when conducted under similar conditions.
Fact Sheet
10/9/2002
The primary purpose of Green Mist was to estimate the effective dosage area coverage that could be expected if sarin nerve agent-filled M139 bomblets were disseminated from four different weapons systems over a rain forest canopy.
Fact Sheet
10/9/2002
The Elk Hunt, Phase II tests were designed to determine the amount of VX nerve agent picked up on the clothing of personnel traversing breached paths through contaminated areas and M23 minefields; the amount of VX nerve agent deposited on the surface of vehicles traversing VX-contaminated areas or under which an M23 mine had been detonated; the amount of VX nerve agent deposited on the clothing of personnel actively or passively contacting contaminated vehicles; vehicle decontamination by wet steam, high-pressure cold water hosing, and wallow pit; and, the amount of VX vapor rising from VX-contaminated areas.
Fact Sheet
10/9/2002
Devil Hole, Phase I was conducted in temperate aspen and spruce forests to determine area-time-dosage information for Sarin nerve agent-filled artillery munitions (M121A1 155mm shells) and Sarin nerve agent –filled rocket warheads (M55 115 mm warheads.)
Fact Sheet
10/9/2002
The purpose of Magic Sword was to study the feasibility of an offshore release of Aedes aegypti mosquitoes and to obtain information on mosquito biting habits, mosquito trap technology, and operational and logistical problems associated with the delivery of mosquitoes to remote sites.
Page 1170 of 1217
, showing items 17536 - 17550
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: September 15, 2022